Cardio Diagnostics Holdings, Inc. Gain (Loss) on Extinguishment of Debt
Cardio Diagnostics Holdings, Inc. (CDIO) reported Gain (Loss) on Extinguishment of Debt of $193.35 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-03-20
- Cardio Diagnostics Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $444.70K.
- Cardio Diagnostics Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was $112.94K.
- Cardio Diagnostics Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-06-30 was -$364.30K.
- Cardio Diagnostics Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
- Cardio Diagnostics Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $193.35K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $444.70K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $557.64K derived: sum of 2 quarters · filed 2025-03-20 | $193.35K derived: sum of 3 quarters · filed 2025-03-20 | $193.35K 10-K · filed 2025-03-20 |
| 2023-09-30 | $112.94K 10-Q · filed 2024-11-13 | -$251.35K derived: sum of 2 quarters · filed 2024-11-13 | -$251.35K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$364.30K 10-Q · filed 2024-08-12 | -$364.30K 10-Q · filed 2024-08-12 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |